Peritoneal Dialysis: Global Update

Fenton S.S.A. , Schaubel D.E. , Desmeules M. , Morrison H.I. , Mao Y. , Copleston P. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis. 1997; 30: 334–42.

Maiorca R. , Cancarini G. , Zubani R. , Camerini C. , Manili L. , Brimori G. CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int. 1996; 16: 276–87.

Gokal R. , Oreopoulos D. Is long term CAPD possible? Perit Dial Int. 1996; 16: 553–5.

Nissenson A.R. , Prichard S.S. , Cheng I. , Gokal R. , Kubota M. , Maiorca R. Non-medical factors that impact on ESRD modality selection. Kidney Int. 1993; 38(Suppl 40): S120–7.

Nissenson A.R. , Prichard S.S. , Cheng I.P.S. , Gokal R. , Kubota M. , Maiorca R. ESRD modality selection into the 21st century: The impact of non-medical factors. ASAIO J. 1997; 43: 143–50.

Nolph K.D. Why are reported relative mortality risks for CAPD and HD so variable? Perit Dial Int. 1996; 16: 15–18.

Bloembergen W.E. , Port F.K. , Mauger E.A. , Wolfe R.A. A comparison of mortality between patients treated with haemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995; 6: 177–83.

Churchill D.N. , Taylor D.W. , Vas SI , and the Canadian CAPD Clinical Trials Group. Peritonitis in CAPD: A multi-centre randomised clinical trial comparing the y-connector disinfectant system to standard system. Perit Dial Int. 1989; 9: 159–63.

Holley J.L. , Bernardini J. , Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the y-set. Am J Kidney Dis. 1994; 23: 569–73.

Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol. 1996; 7: 198–207.

National Kidney Foundation Dialysis Outcomes Quality Initiative. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 1997; 30(Suppl 2): S67–136.

Flessner M.F. Peritoneal transport physiology: Insights from basic research. J Am Sac Nephrol. 1991; 2: 122–35.

Ho-dac-Pannekeet M.M. , Krediet R.T. Water channels in the peritoneum. Perit Dial Int. 1996; 16: 255–9.

Ho-dac-Pannekeet M.M. , Atasever B. , Struijk D.G. , Krediet R.T. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of a standard permeability analysis (SPA). Perit Dial Int. 1997; 17: 144–50.

Churchill D.N. , Thorpe K.E. , Nolph K.D. , Keshaviah P.R. , Oreopoulos D.G. , Page D. Increased peritoneal transport - association with decreased patient and technique survival. J Am Soc Nephrol. 1998; 9: 1285–92.

Davies S.J. , Bryan J. , Phillips L. , Russell G.I. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant. 1996; 11: 498–506.

Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int. 1993; 43(Suppl 40): S106–10.

Coles G.A. Have we underestimated the importance of fluid balance for the survival of PD patients? Perit Dial Int. 1997; 17: 321–6.

Jörres A. , Williams J.D. , Topley N. Peritoneal dialysis solution biocompatibility: Inhibitory mechanisms and recent studies with bicarbonate buffered solutions. Perit Dial Int. 1997; 17(Suppl 2): S42–5.

Nakayama M. , Kawaguchi Y. , Yamada K. , Hasegawa T. , Takazoe K. , Katoh N. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997; 51: 182–6.

Gotloib L. , Shostak A. , Wajsbrot V. Detrimental effects of peritoneal dialysis solutions upon in vivo and in situ exposed mesothelium. Perit Dial Int. 1997; 17(Suppl 2): S13–16.

Coles G. , Gokal R. , Ogg C. , Jani F. , O'Donoghue D. , Cancarini G. A randomized controlled trial of a bicarbonate and bicarbonate/lactate containing dialysis fluid in CAPD. Perit Dial Int. 1997; 17: 48–51.

Peers E. , Gokal R. Icodextrin: Overview of clinical experience. Perit Dial Int. 1997; 17: 22–6.

Rippe B. , Simonsen O. , Wieslander A. , Landren C. Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int. 1997; 17: 27–34.

Wilkie M.E. , Plant M.J. , Edwards J. , Brown C. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of CAPD technique survival. Perit Dial Int. 1997; 17: 84–7.

Gokal R. , Alexander S. , Ash S. , Chen W. , Danielson A. , Holmes C. Peritoneal catheter and exit site practices towards optimum peritoneal access: 1998 update. Perit Dial Int. 1998; 18: 11–33.

The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infections during peritoneal dialysis. J Am Soc Nephrol. 1997; 11: 2403–8.

Thodis E. , Bhaskaran S. , Pasadakis P. , Bargman J. , Vas S.I. , Oreopoulos D.G. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int. 1998; 18: 261–70.

Van Biesen W. , De Vogeleere P. , Vijt D. , Vanholder R. , Lameire N. Integrated care can improve long-term survival of ESRD patients [Abstract]. Perit Dial Int. 1998; 18: 138.

Charytan C. , Spinovitz B.S. , Galler M. A comparative study of CAPD and in centre HD. Arch Intern Med. 1986; 146: 1138–43.

Burton P.R. , Walls J. A selection adjusted comparison of life expectancy of patients on CAPD, haemodialysis and renal transplantation. Lancet. 1987; 1: 1115–19.

Gokal R. , Jakubowski C. , King C. , Hunt L. , Boyle S. , Baillod R. Outcome in patients on CAPD and hemodialysis: A four year analysis of a prospective multicentre study. Lancet. 1987; II: 1105–9.

Serkes K.D. , Blagg C.R. , Nolph K.D. , Vonesh E. , Shapiro F. Comparison of patients and techniques in CAPD and hemodialysis: A multi-center study. Perit Dial Int. 1990; 10: 15–19.

Cavalli P. , Viglino G. , Goia F. , Cottino R. , Mariano F. , Gandolfo C. CAPD versus hemodialysis: 7 years experience. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Bulletin, 1989; 5: 52–5.

Maiorca R. , Vonesh E.F. , Cavalli P.L. , De Vecchi A. , Giangrande A. , LaGreca G. A multicentre selection adjusted comparison of patient and technique survival on CAPD and hemodialysis. Perit Dial Int. 1991; 11: 1148–57.

Disney A.P.S. , for the Australia and New Zealand Dialysis, and Transplant Registry. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand. Am J Kidney Dis. 1995; 25: 165–75.

Mallick N.P. , Jones E. , Selwood N. The European (European Dialysis and Transplantation Association -European Renal Association) Registry. Am J Kidney Dis. 1995; 25: 176–87.

Lupo A. , Tarchini R. , Cancarini G. , Catizone L. , Cocchi R. , De Vecchi A. Long term outcome in CAPD: A 10 year survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis. 1994; 24: 826–37.

Teraoka S. , Toma H. , Nihei H. , Ota K. , Babazono T. , Ishikawa I. Current status of renal replacement therapy in Japan. Am J Kidney Dis. 1995; 25: 151–64.

Held P.J. , Port F.K. , Turenne M.N. , Gaylin D.S. , Hamburger R.T. , Wolfe R.A. CAPD and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994; 45: 1163–9.